Search Prime Grants

C06OD039892

Project Grant

Overview

Grant Description
WSU ADVANCED TECHNOLOGY CENTER: CENTRALIZATION AND MODERNIZATION OF CORE FACILITIES - THIS PROPOSAL AIMS TO ESTABLISH THE WAYNE STATE UNIVERSITY ADVANCED TECHNOLOGY CENTER (ATC) FOR CUTTING-EDGE ANALYTICAL TECHNOLOGIES OCCUPYING 10,425 SQUARE FEET IN THE NEW HEALTH SCIENCES BUILDING (HSB) ON THE WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE (WSU-SOM) CAMPUS. DEVELOPED WITH THE MOTT CENTER, BARBARA ANN KARMANOS CANCER INSTITUTE (KCI), AND THE INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES (IEHS), THIS INITIATIVE WILL FACILITATE INNOVATIVE BIOMEDICAL RESEARCH THROUGH TECHNOLOGIES PROVIDED BY CORE FACILITY LABORATORIES. THE ATC WILL PROVIDE STATE-OF-THE-ART INSTRUMENTATION AND EXPERTISE TO SUPPORT MULTIDISCIPLINARY EFFORTS IN UNDERSTANDING DISEASE MECHANISMS, DEVELOPING NOVEL THERAPIES, AND ADDRESSING CRITICAL HEALTH CHALLENGES, PARTICULARLY THOSE AFFECTING URBAN AND RURAL POPULATIONS. THE ATC WILL CENTRALIZE THE MICR (MICROSCOPY, IMAGING AND CYTOMETRY, RESOURCES), PROTEOMIC, AND LIPIDOMIC CORE FACILITIES, WHICH ARE CURRENTLY DISPERSED ACROSS FOUR AGING BUILDINGS. THESE CORES EVOLVED INDEPENDENTLY OVER DECADES, RESULTING IN PHYSICAL SEPARATION AND LIMITED INTERACTION. CENTRALIZATION IN THE ATC WHILE MODERNIZING ITS INFRASTRUCTURE WILL OPTIMIZE RESOURCE UTILIZATION AND FOSTER COLLABORATIVE RESEARCH. WSU INVESTIGATORS AND EXTERNAL USERS RELY ON THESE CORES TO ANALYZE SAMPLES FROM PRECIOUS PATIENT BIOPSIES, CONTROLLED ANIMAL STUDIES, AND IN VITRO EXPERIMENTS. HOWEVER, THEIR PHYSICAL SEPARATION LIMITS THE FEASIBILITY AND EFFICIENCY OF MULTI-OMIC RESEARCH EFFORTS. SAMPLES OFTEN REQUIRE PARTITIONING FOR SEPARATE ANALYSES AT DIFFERENT FACILITIES, CREATING REDUNDANCY IN RECORD KEEPING AND REGULATORY OVERSIGHT WHILE AT THE SAME TIME REDUCING THE ABILITY TO EXTRACT COMPREHENSIVE, INTERCONNECTED DATA. THE CENTRALIZED ATC ADDRESSES THESE CHALLENGES BY FACILITATING THE DEVELOPMENT OF PROTOCOLS ACROSS CORES, UTILIZING A SINGLE REPORTING AND OVERSIGHT MECHANISM WHILE PROVIDING DIFFERENT TECHNOLOGIES, AND ENABLING SEAMLESS INTEGRATION OF ADVANCED EXPERIMENTAL DESIGN. FOR INSTANCE, BIOBANK SPECIMENS, PATIENT SAMPLES, OR TOXICANT-EXPOSED TISSUES CAN UNDERGO SPECIALIZED IMAGING, CELL SORTING, AND OMICS ANALYSES IN A SEAMLESS WORKFLOW. THIS INTEGRATED APPROACH WILL MAXIMIZE DATA GENERATION, ENHANCE SCIENTIFIC DISCOVERY, AND ADVANCE INVESTIGATOR INITIATIVES. THE ATC WILL DRIVE INNOVATION BEYOND WHAT EACH CORE COULD ACHIEVE INDIVIDUALLY, YIELDING BENEFITS FAR GREATER THAN THE SUM OF ITS PARTS. WSU’S CORE LABORATORIES SUPPORT A BROAD USER BASE, INCLUDING INVESTIGATORS FROM REGIONAL, NATIONAL, AND INTERNATIONAL INSTITUTIONS. THE ATC WILL ENHANCE WSU’S REPUTATION AS A PREMIER RESOURCE FOR ADVANCED TECHNOLOGICAL SOLUTIONS, OFFERING HIGH-QUALITY SERVICES, TRAINING, WORKSHOPS, AND EDUCATIONAL OPPORTUNITIES. THE ATC WILL IMPROVE THE EFFICIENCY AND IMPACT OF RESEARCH WHILE ALSO PREPARING THE NEXT GENERATION OF SCIENTISTS THROUGH COMPREHENSIVE TRAINING PROGRAMS, INCLUDING EXPERIENTIAL LEARNING OPPORTUNITIES DESIGNED TO ENGAGE YOUNG SCIENTISTS. ONGOING OUTREACH TO AREA SCHOOLS, INCLUDING A SUMMER TRAINING PROGRAM, DEMONSTRATES OUR STRUCTURED AND SUSTAINABLE COMMITMENT TO EDUCATIONAL OUTREACH.
Funding Goals
TO RENOVATE EXISTING RESEARCH FACILITIES AND BUILD NEW RESEARCH FACILITIES TO MEET BASIC AND CLINICAL SPACE REQUIREMENTS, LABORATORY SAFETY, BIOHAZARD CONTAINMENT, AND ANIMAL CARE STANDARDS IN ORDER TO SUPPORT THE FACILITY DEMANDS OF NIH RESEARCH PROGRAMS.
Grant Program (CFDA)
Place of Performance
Detroit, Michigan 48201 United States
Geographic Scope
Single Zip Code
Wayne State University was awarded WSU ATC: Centralization of Core Facilities Project Grant C06OD039892 worth $8,000,000 from the National Institute of Allergy and Infectious Diseases in September 2025 with work to be completed primarily in Detroit Michigan United States. The grant has a duration of 3 years 2 months and was awarded through assistance program 93.352 Construction Support. The Project Grant was awarded through grant opportunity Biomedical Research Facilities (C06 Clinical Trial Not Allowed).

Status
(Ongoing)

Last Modified 9/24/25

Period of Performance
9/15/25
Start Date
11/30/28
End Date
1.0% Complete

Funding Split
$8.0M
Federal Obligation
$0.0
Non-Federal Obligation
$8.0M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to C06OD039892

Additional Detail

Award ID FAIN
C06OD039892
SAI Number
C06OD039892-3684578634
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75AGNA NIH AGGREGATE FINANCIAL ASSISTANCE DATA AWARDING OFFICE
Funding Office
75NA00 NIH OFFICE OF THE DIRECTOR
Awardee UEI
M6K6NTJ2MNE5
Awardee CAGE
2B019
Performance District
MI-13
Senators
Debbie Stabenow
Gary Peters
Modified: 9/24/25